Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Condensed Consolidated Interim Statements of Comprehensive Loss (Unaudited)

v3.19.2
Condensed Consolidated Interim Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Profit or loss [abstract]        
Revenue $ 606 $ 182 $ 1,200 $ 407
Cost of Revenue 453 67 858 92
Gross Profit 153 115 342 315
Operating costs and expenses:        
Research and development expenses, net: 797 641 1,672 1,932
General, administrative and marketing expenses 944 863 1,814 1,859
Total operating costs and expenses: 1,741 1,504 3,486 3,791
Operating loss 1,588 1,389 3,144 3,476
Financial income (325) (47) (25)
Financial expenses 64 247 237 180
Exchange differences 193 (40) 177 11
Financial expenses (income), net (68) 160 414 166
Loss for the period 1,520 1,549 3,558 3,642
Other comprehensive loss:        
Currency translation differences 170 313
Total comprehensive loss for the period $ 1,520 $ 1,719 $ 3,558 $ 3,955
Basic and diluted loss per ordinary share $ 0.33 $ 0.36 [1] $ 0.76 $ 0.88 [1]
Weighted average ordinary shares outstanding 4,661,506 4,348,579 [1] 4,660,862 4,137,683 [1]
[1] After reverse split, see note 5B.